Pasithea Therapeutics Corporation.

KTTA·NASDAQ·$0.68Share Price as of 11/2·$5MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report09/16/26 8-KCurrent report09/09/26 8-KCurrent report05/04/26 8-KCurrent report02/20/26 8-KCurrent report01/28/26

Prospectuses and Registrations

S-8Registration of securities for employees01/30/26 POS AMPost-effective amendment01/26/26 424B4Prospectus12/01/25 S-1/ARegistration statement (amended)11/26/25 S-1Registration statement (IPO)11/18/25

Proxies

DEF 14ADefinitive proxy08/07/26 PRE 14APreliminary proxy07/29/26 DEF 14ADefinitive proxy12/29/25 PRE 14APreliminary proxy12/19/25 DEF 14ADefinitive proxy07/24/25

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)07/31/26 SC 13G/ABeneficial ownership (amended)07/01/26 SC 13GBeneficial ownership06/23/26 Form 4Insider transaction06/22/26

Other

25-NSERemoval from listing09/16/26 ARSAnnual report to shareholders08/07/26 EFFECTRequest for effectiveness01/27/26 EFFECTRequest for effectiveness11/28/25 CORRESPCorrespondence with the SEC11/26/25